In-vivo retroviral gene transfer to the liver is cancelled by an immune response against the corrected cells. Can it be avoided? by G. Podevin et al.
In-vivo retroviral gene transfer to the liver is cancelled by an
immune response against the corrected cells. Can it be
avoided?
Submitted by Guillaume Podevin on Fri, 12/05/2014 - 16:06
Titre In-vivo retroviral gene transfer to the liver is cancelled by an immune responseagainst the corrected cells. Can it be avoided?
Type de
publication Article de revue
Auteur Podevin, Guillaume [1], Pichard, Virginie [2], Durand, Sophie [3], Aubert, Dominique[4], Heloury, Yves [5], Ferry, Nicolas [6]
Editeur Springer Verlag
Type Article scientifique dans une revue à comité de lecture
Année 2002
Langue Anglais
Date 2002 Oct
Pagination 595-9
Volume 18
Titre de la
revue Pediatric Surgery International
ISSN 0179-0358
Mots-clés
Animals [7], beta-Galactosidase [8], Gene Transfer Techniques [9], Genetic Therapy
[10], Hepatectomy [11], Liver [12], Liver Regeneration [13], Male [14], Rats [15],
Rats, Wistar [16], Retroviridae [17]
Résumé en
anglais
Highly efficient retroviral-mediated gene transfer into hepatocytes in vivo has been
previously reported in rats, but some reports described transient expression of the
transgene that may be related to induction of an immune response against the
transgene product. To devise a surgical approach to circumvent this drawback, two-
thirds partial hepatectomy was performed in Wistar male rats to induce the
hepatocyte division required to achieve retrovirus integration. Delivery of
amphotrophic retroviral vectors (RVV) encoding Escherichia coli beta-galactosidase
was performed 24 h after partial hepatectomy. In a first group (n = 11), gene
delivery was performed by peripheral injection of 2 ml retrovirus-containing
medium. For the second group (n = 11), asanguineous perfusion of the regenerating
liver after complete vascular exclusion was carried out with 20 ml viral solution.
Liver biopsies were performed sequentially in each group. In the first group, beta-
galactosidase was expressed at day 7 in 7 +/- 6.3% of hepatocytes and the labeled
hepatocytes had disappeared in less than 4 weeks. Polymerase chain reaction
experiments demonstrated the elimination of the transduced cells and the
appearance of antibodies against beta-galactosidase. Of the 11 rats in the second
group, 8 were still able to express beta-galactosidase more than 6 weeks after
asanguineous perfusion with no detectable antibody response. Asanguineous
perfusion of the regenerating liver with RVV after complete vascular exclusion
enabled long-term expression in rats and avoided the immune response present after
peripheral delivery in most animals. These results suggest that the immune reaction
is secondary to viral infection of antigen presenting cells. Asanguineous perfusion
could thus be a way to perform gene therapy for inherited liver diseases without
immunosuppressive therapy.
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